1. Home
  2. MSGY vs PRPH Comparison

MSGY vs PRPH Comparison

Compare MSGY & PRPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MSGY

Masonglory Limited Ordinary Shares

N/A

Current Price

$2.83

Market Cap

24.0M

Sector

N/A

ML Signal

N/A

Logo ProPhase Labs Inc. (DE)

PRPH

ProPhase Labs Inc. (DE)

HOLD

Current Price

$0.13

Market Cap

21.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MSGY
PRPH
Founded
2018
1989
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
24.0M
21.9M
IPO Year
2025
1997

Fundamental Metrics

Financial Performance
Metric
MSGY
PRPH
Price
$2.83
$0.13
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
1.7M
3.2M
Earning Date
12-12-2025
11-19-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
$23,318,482.00
$5,055,000.00
Revenue This Year
N/A
$221.82
Revenue Next Year
N/A
N/A
P/E Ratio
$27.08
N/A
Revenue Growth
13.04
N/A
52 Week Low
$0.83
$0.12
52 Week High
$22.20
$0.93

Technical Indicators

Market Signals
Indicator
MSGY
PRPH
Relative Strength Index (RSI) N/A 24.58
Support Level N/A $0.12
Resistance Level N/A $0.22
Average True Range (ATR) 0.00 0.03
MACD 0.00 -0.00
Stochastic Oscillator 0.00 4.23

Price Performance

Historical Comparison
MSGY
PRPH

About MSGY Masonglory Limited Ordinary Shares

Masonglory Ltd is a a holding company and operates through subsidiary. It is engaged in the provision of wet trades services and other ancillary services as a subcontractor in Hong Kong. As a subcontractor, It provide customers with comprehensive wet trades works solutions, which principally include plastering on floors, ceilings and walls, tile laying on internal and external walls and floors, brick laying, floor screeding, and marble works.

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company offering various services, including diagnostic testing, genomics testing, and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers, and government organizations. The Consumer Products segment is engaged in the research, development, manufacture, distribution, marketing, and sale of OTC consumer healthcare products and dietary supplements in the United States. It also provides personal genomics products and services.

Share on Social Networks: